Related Experiment Video
Updated: Nov 22, 2025
06:48
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
21.8K
Looking into the future: Gene and cell therapies for glaucoma
András M Komáromy1, Kristin L Koehl1, Shin Ae Park1,2
1College of Veterinary Medicine, Michigan State University, East Lansing, MI, USA.
Veterinary Ophthalmology
|January 7, 2021
Summary
Gene and cell therapies offer promising new avenues for treating glaucoma by targeting underlying mechanisms. While clinical translation for glaucoma is limited, these advanced therapies hold potential for long-term vision preservation.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Genetics
Background:
- Glaucoma is a complex optic neuropathy characterized by elevated intraocular pressure (IOP), leading to retinal ganglion cell (RGC) loss and vision impairment.
- Current treatments focus on lowering IOP but do not offer a cure, and vision loss can persist despite therapy.
- Advances in understanding glaucoma mechanisms and risk factors enable earlier diagnosis and more effective treatment strategies.
Purpose of the Study:
- To explore the potential of gene and cell therapies as novel treatment modalities for glaucoma.
- To review the progress and challenges in developing and translating these therapies for ocular conditions.
- To identify specific applications of gene and cell therapies for glaucoma management.
Main Methods:
- Review of current literature on gene and cell therapy research in the context of glaucoma and other ocular diseases.
- Analysis of laboratory and preclinical advancements in therapeutic approaches for glaucoma.
- Examination of clinical translation successes and limitations for gene and cell therapies in ophthalmology.
Main Results:
- Gene and cell therapies show potential for specific targeting of glaucoma mechanisms, offering lasting therapeutic effects.
- These therapies have been successfully translated into clinical applications for inherited retinal dystrophies and age-related macular degeneration (AMD).
- Clinical translation for glaucoma remains limited, with only intravitreal CNTF for RGC neuroprotection showing some application.
Conclusions:
- Gene and cell therapies represent a significant frontier in glaucoma treatment, moving beyond IOP reduction.
- Potential applications include long-term IOP control, RGC neuroprotection and regeneration, and modulation of ocular biomechanics.
- Further research and clinical translation are crucial to realize the full potential of these advanced therapies for preventing irreversible vision loss in glaucoma patients.
Related Concept Videos
00:59Gene Therapy
26.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.8K
01:27Open Angle Glaucoma: Treatment
832
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
832
01:28Angle Closure Glaucoma: Treatment
957
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
957
01:25Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
01:22iPS Cell Differentiation
2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K